A Study of Ultrasonic Peripheral Perfusion Imaging

Overview

About this study

The purpose of this study is to evaluate the potential of ultrasound perfusion imaging technique for assessing the progression of peripheral arterial disease (PAD) and monitoring its response to therapy by measuring changes in microvessel alterations and perfusion variations.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria - Patients Having Taken ABI Test:

Male and female volunteers > 18 years old.
Male and female volunteers with symptom of claudication and suspected peripheral arterial disease (PAD) who are scheduled for vascular testing.

Exclusion Criterian - Patients Having Taken ABI Test:

Patients with gangrene.
Patients with lower leg amputation.
Having ulcer and any health condition that does not allow proper use of ultrasound scanning.
People considered in “vulnerable” populations.
Patients with previously placed stents in their leg(s).

Inclusion Criteria - Normal ABI and Healthy:

Healthy volunteers.
Age matched with the PAD group.

Exclusion Criteria - Normal ABI and Healthy:

Current smokers.
Uncontrolled hypertension.
Unstable angina.
Diabetes.
Congestive heart failure.
Critical limb ischemia.
Patients with previously placed stents in their leg(s).
Surgery in legs.
Having ulcer and any health condition that does not allow proper use of ultrasound scanning.
People considered in “vulnerable” populations.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 9/25/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Azra Alizad, M.D.	Open for enrollment	Contact information: Fatima Zohra (507) 422-5069 Zohra.Fatima@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Azra Alizad, M.D.

Open for enrollment

Contact information:

Fatima Zohra

(507) 422-5069

Zohra.Fatima@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials